National Rheumatoid Arthritis Society announces new Chief Medical Advisor – January 202627 January 2026 The National Rheumatoid Arthritis Society (NRAS), are delighted to announce the appointment of a new Chief Medical Advisor (CMA), Professor James Galloway MBChB, MSc, CHP, MRCP, PhD. Prof. Galloway is Professor of Rheumatology at King’s College London, a leading researcher in the field of inflammatory autoimmune diseases and an Honorary Consultant Rheumatologist at King’s College Hospital NHS Foundation Trust, London. Prof. Galloway takes over as NRAS CMA from Peter Taylor MA, PhD, FRCP, FRCPE, Emeritus Professor of Musculoskeletal Sciences, University of Oxford who held the roll for a period of 10 years, stepping down at the end of 2024 with the grateful thanks of the whole NRAS community for his long commitment to this voluntary role. Prof. Galloway has been a long-standing supporter of NRAS dating back to the early days of the charity. He has been involved in many NRAS projects and campaigns to improve access to care and patient outcomes. Notably Prof. Galloway represented NRAS alongside Prof. Taylor in a 3 year campaign, in collaboration with the British Society for Rheumatology, for earlier access to anti TNF drugs for people with moderate disease. This campaign culminated in NICE approving a limited range of advanced therapies for this cohort of patients with a change in the guidance effective July 2021 potentially ending avoidable suffering for up to 25,000 people. NRAS places great importance on gathering evidence of lived experience and real world data to advocate for people living with Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis (JIA). They are looking forward to benefitting from Prof. Galloway’s expertise and knowledge in the field of epidemiological research as well as his experience as data lead for the National Early Inflammatory Autoimmune Diseases Audit (NEIAA). NRAS looks forward to even closer collaboration with Prof. Galloway over the next few years and welcomes him warmly to the NRAS family. Peter Foxton, NRAS CEO said, We are delighted to welcome James as our new Chief Medical Officer and look forward to working with him as we continue in our purpose to inform and support people with Rheumatoid Arthritis and Juvenile Idiopathic Arthritis and campaign for improvements to care and treatments. Prof. Galloway said, “It is an enormous honour to have been asked to work with NRAS as their CMA. They have been an enormous support to me throughout my career – both to patients I have looked after, but also to me personally. I am always astonished by how passionately they champion the cause – fighting for access to the best care, best treatments, and of course helping shape the research agenda for people with rheumatoid arthritis. I am very much looking forward to continuing working with them for many years to come!”